Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt

Hepatology

Volumn 61, Issue 3, 2015, Pages 834-842

  Benova, Lenka ^a,b   Awad, Susanne F ^a   Miller, F Dewolfe ^c   Abu Raddad, Laith J ^a,d,e  

^a WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF HAWAII   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; BIRTH; COHORT ANALYSIS; CONCEPTUAL FRAMEWORK; EGYPT; EGYPTIAN; EPIDEMIC; FEMALE; FEMALE FERTILITY; HEPATITIS C; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MARRIED WOMAN; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; RURAL POPULATION; URBAN AREA; URBAN POPULATION; VERTICAL TRANSMISSION; YOUNG ADULT; BLOOD; PREGNANCY;

HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; EGYPT; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INCIDENCE; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MIDDLE AGED; PREGNANCY;

EID: 84923448279     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27596     Document Type: Article

References (49)

1. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007;13:2436-2441.
2. El-Zanaty F, Way A. Egypt Demographic and Health Survey 2008. Cairo: Ministry of Health, El-Zanaty and Associates, and Macro International; 2009.
3. Bruggmann P, Berg T, Ovrehus AL, Moreno C, Brandao Mello CE, Roudot-Thoraval F, et al. Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat 2014;21(Suppl 1):5-33.
4. Strickland GT. Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. HEPATOLOGY 2006;43:915-922.
5. Deuffic-Burban S, Mohamed MK, Larouze B, Carrat F, Valleron AJ. Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. J Hepatol 2006;44:455-461.
6. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000;355:887-891.
7. Cuadros DF, Branscum AJ, Miller FD, Abu-Raddad LJ. Spatial epidemiology of hepatitis C virus infection in Egypt: analyses and implications. HEPATOLOGY 2014;60:1150-1159.
8. National Committee for the Control of Viral Hepatitis. Egyptian National Control Strategy for Viral Hepatitis 2008-2012. Cairo: Arab Republic of Egypt, Ministry of Health and Population; 2008 (April).
9. Arafa N, El Hoseiny M, Rekacewicz C, Bakr I, El-Kafrawy S, El Daly M, et al. Changing pattern of hepatitis C virus spread in rural areas of Egypt. J Hepatol 2005;43:418-424.
10. Habib M, Mohamed MK, Abdel-Aziz F, Magder LS, Abdel-Hamid M, Gamil F, et al. Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. HEPATOLOGY 2001;33:248-253.
11. Mohamed MK, Magder LS, Abdel-Hamid M, El-Daly M, Mikhail NN, Abdel-Aziz F, et al. Transmission of hepatitis C virus between parents and children. Am J Trop Med Hyg 2006;75:16-20.
12. Esmat G, Hashem M, El-Raziky M, El-Akel W, El-Naghy S, El-Koofy N, et al. Risk factors for hepatitis C virus acquisition and predictors of persistence among Egyptian children. Liver Int 2012;32:449-456.
13. Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect Dis 2013;13:288.
14. Mostafa A, Taylor SM, el-Daly M, el-Hoseiny M, Bakr I, Arafa N, et al. Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections. Liver Int 2010;30:560-566.
15. Mohamed MK, Abdel-Hamid M, Mikhail NN, Abdel-Aziz F, Medhat A, Magder LS, et al. Intrafamilial transmission of hepatitis C in Egypt. HEPATOLOGY 2005;42:683-687.
16. Plancoulaine S, Mohamed MK, Arafa N, Bakr I, Rekacewicz C, Tregouet DA, et al. Dissection of familial correlations in hepatitis C virus (HCV) seroprevalence suggests intrafamilial viral transmission and genetic predisposition to infection. Gut 2008;57:1268-1274.
17. Tovo PA, Lazier L, Versace A. Hepatitis B virus and hepatitis C virus infections in children. Curr Opin Infect Dis 2005;18:261-266.
18. Pappalardo BL. Influence of maternal human immunodeficiency virus (HIV) co-infection on vertical transmission of hepatitis C virus (HCV): a meta-analysis. Int J Epidemiol 2003;32:727-734.
19. Polis CB, Shah SN, Johnson KE, Gupta A. Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: a meta-analysis. Clin Infect Dis 2007;44:1123-1131.
20. Syriopoulou V, Nikolopoulou G, Daikos GL, Theodoridou M, Pavlopoulou I, Nicolaidou P, Manolaki N. Mother to child transmission of hepatitis C virus: rate of infection and risk factors. Scand J Infect Dis 2005;37:350-353.
21. Mast EE, Hwang LY, Seto DS, Nolte FS, Nainan OV, Wurtzel H, Alter MJ. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 2005;192:1880-1889.
22. Resti M, Bortolotti F, Azzari C, Giacchino R, Zancan L, Gussetti N, Vierucci A. Transmission of hepatitis C virus from infected mother to offspring during subsequent pregnancies. J Pediatr Gastroenterol Nutr 2000;30:491-493.
23. Yeung LT, King SM, Roberts EA. Mother-to-infant transmission of hepatitis C virus. HEPATOLOGY 2001;34:223-229.
24. Shiraki K, Ohto H, Inaba N, Fujisawa T, Tajiri H, Kanzaki S, et al. Guidelines for care of pregnant women carrying hepatitis C virus and their infants. Pediatr Int 2008;50:138-140.
25. Bhola K, McGuire W. Does avoidance of breast feeding reduce mother-to-infant transmission of hepatitis C virus infection? Arch Dis Child 2007;92:365-366.
26. Cottrell EB, Chou R, Wasson N, Rahman B, Guise JM. Reducing risk for mother-to-infant transmission of hepatitis C virus: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2013;158:109-113.
27. Saleh DA, Shebl FM, El-Kamary SS, Magder LS, Allam A, Abdel-Hamid M, et al. Incidence and risk factors for community-acquired hepatitis C infection from birth to 5 years of age in rural Egyptian children. Trans R Soc Trop Med Hyg 2010;104:357-363.
28. Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat. World Population Prospects: The 2010 Revision. New York: United Nations; 2011.
29. Lehman EM, Wilson ML. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality. J Viral Hepat 2009;16:650-658.
30. Miller FD, Abu-Raddad LJ. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci U S A 2010;107:14757-14762.
31. Breban R, Doss W, Esmat G, Elsayed M, Hellard M, Ayscue P, et al. Towards realistic estimates of HCV incidence in Egypt. J Viral Hepat 2013;20:294-296.
32. Miller FD, Abu-Raddad LJ. Quantifying current hepatitis C virus incidence in Egypt. J Viral Hepat 2013;20:666-667.
33. Resti M, Bortolotti F, Vajro P, Maggiore G. Guidelines for the screening and follow-up of infants born to anti-HCV positive mothers. Dig Liver Dis 2003;35:453-457.
34. Saleh DA, Shebl F, Abdel-Hamid M, Narooz S, Mikhail N, El-Batanony M, et al. Incidence and risk factors for hepatitis C infection in a cohort of women in rural Egypt. Trans R Soc Trop Med Hyg 2008;102:921-928.
35. Central Agency for Public Mobilization and Statistics. Population in governorates (urban/rural) according to final results of 2006 population census. Cairo: CAPMAS; 2013.
36. Jabeen T, Cannon B, Hogan J, Crowley M, Devereux C, Fanning L, et al. Pregnancy and pregnancy outcome in hepatitis C type 1b. QJM 2000;93:597-601.
37. Zuccotti GV, Salvini F, Farina F, Agostoni C, Riva E, Giovannini M. Longitudinal long-term follow-up study of children with vertically acquired hepatitis C virus infection. J Int Med Res 2006;34:215-222.
38. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. HEPATOLOGY 2009;49:1335-1374.
39. Abu-Raddad LJ, Hilmi N, Mumtaz G, Benkirane M, Akala FA, Riedner G, et al. Epidemiology of HIV infection in the Middle East and North Africa. AIDS 2010;24(Suppl 2):S5-23.
40. National AIDS Program Egypt. Global AIDS response progress report 2012: Arab Republic of Egypt. Cairo: Ministry of Health; 2012.
41. Abu-Raddad L, Akala FA, Semini I, Riedner G, Wilson D, Tawil O. Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: time for strategic action. Middle East and North Africa HIV/AIDS Epidemiology Synthesis Project. World Bank/UNAIDS/WHO Publication. Washington, DC: The World Bank Press; 2010.
42. Shebl FM, El-Kamary SS, Saleh DA, Abdel-Hamid M, Mikhail N, Allam A, et al. Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages. J Med Virol 2009;81:1024-1031.
43. Benova L, Mohamoud YA, Calvert C, Abu-Raddad LJ. Vertical transmission of hepatitis C: systematic review and meta-analysis. Clin Infect Dis 2014;59:765-773.
44. Yeung LT, To T, King SM, Roberts EA. Spontaneous clearance of childhood hepatitis C virus infection. J Viral Hepat 2007;14:797-805.
45. Lawitz E, Poordad FF, Pang PS, Hyland RH, Ding X, Mo H, et al. Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial. Lancet 2014;383:515-523.
46. Asselah T. Sofosbuvir for the treatment of hepatitis C virus. Expert Opin Pharmacother 2014;15:121-130.
47. Arshad M, El-Kamary SS, Jhaveri R. Hepatitis C virus infection during pregnancy and the newborn period-are they opportunities for treatment? J Viral Hepat 2011;18:229-236.
48. Pembrey L, Newell ML, Tovo PA. The management of HCV infected pregnant women and their children European paediatric HCV network. J Hepatol 2005;43:515-525.
49. Wirth S. Current treatment options and response rates in children with chronic hepatitis C. World J Gastroenterol 2012;18:99-104.